Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis

Marine Drugs

Volumn 12, Issue 2, 2014, Pages 871-885

  Tareq, Fakir Shahidullah ^a,b   Lee, Min Ah ^b   Lee, Hyi Seung ^b   Lee, Jong Seok ^b   Lee, Yeon Ju ^b   Shin, Hee Jae ^a,b  

^a University of Science and Technology (UST)   (South Korea)

^b Korea Research Institute of Ships and Ocean Engineering   (South Korea)

Author keywords

Antimicrobial activity; Bacillus subtilis; Cytotoxicity; Lipopeptides

Indexed keywords

3 BETA HYDROXY 11 METHYLTRIDECANOIC ACID; 3 BETA HYDROXY 9,11 DIMETHYLTRIDECANOIC ACID; 7,9 DIMETHYLUNDEC 2 ENOIC ACID; AMPHOTERICIN B; AZITHROMYCIN; FATTY ACID; GAGEOSTATIN A; GAGEOSTATIN B; GAGEOSTATIN C; LIPOPEPTIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BOTRYTIS CINEREA; BREAST CANCER; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; COLLETOTRICHUM ACUTATUM; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; KIDNEY CANCER; LUNG CANCER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; RHIZOCTONIA SOLANI; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STEREOCHEMISTRY; STOMACH CANCER;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; BACILLUS SUBTILIS; BACTERIA; CELL LINE, TUMOR; FATTY ACIDS; FERMENTATION; FUNGI; HUMANS; LIPOPEPTIDES; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; STEREOISOMERISM;

EID: 84896704517     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12020871     Document Type: Article

References (37)

1. Ebada, S.S.; Lin, W.H.; Proksch, P. Review: Bioactive sesterterpenes and triterpenes from marine sponges: Occurrence and pharmacological significance. Mar. Drugs 2010, 8, 313-346.
2. Feling, R.H.; Buchanan, G.O.; Mincer, T.J.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora. Angew. Chem. Int. Ed. 2003, 42, 355-357.
3. Rampelotto, P.H. Review: Resistance of microorganisms to extreme environmental conditions and its contribution to astrobiology. Sustainability 2010, 2, 1602-1623.
4. Earl, A.M.; Losick, R.; Kolter, R. Ecology and genomics of Bacillus subtilis. Trends Microbiol. 2008, 16, 269-275.
5. Chen, X.H.; Koumoutsi, A.; Scholz, R.; Eisenreich, A.; Schneider, K.; Heinemeyer, I.; Morgenstern, B.; Voss, B.; Hess, W.R.; Reva, O. Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42. Nat. Biotechnol. 2007, 25, 1007-1014.
6. Kunst, F.; Ogasawara, N.; Moszer, I.; Albertini, A.M.; Alloni, G.; Azevedo, V.; Bertero, M.G.; Bessières, P.; Bolotin, A.; Borchert, S. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 1997, 390, 249-256.
7. Fan, L.; Bo, S.; Chen, H.; Ye, W.; Kleinschmidt, K.; Baumann, H.I.; Imhoff, J.F.; Kleine, M.; Cai, D. Genome sequence of Bacillus subtilis subsp. spizizenii gtP20b, isolated from the Indian ocean. J. Bacteriol. 2011, 193, 1276-1277.
8. Hamdache, A.; Lamarti, A.; Aleu, J.; Collado, I.G. Non-peptide metabolites from the genus Bacillus. J. Nat. Prod. 2011, 74, 893-899.
9. Baruzzi, F.; Quintieri, L.; Morea, M.; Caputo, L. Science against Microbial Pathogens: Communicating Current Research and Technological Advances; Vilas, A.M., Ed.; Formatex: Badajoz, Spain, 2011; pp. 1102-1111.
10. Mondol, M.A.M.; Shin, H.J.; Islam, M.T. Diversity of secondary metabolites from marine Bacillus species: Chemistry and biological activity. Mar. Drugs 2013, 11, 2846-2872.
11. Zou, A.; Liu, J.; Garamus, V.M.; Zheng, K.; Willumeit, R.; Mu, B. Interaction between the natural lipopeptide [Glu1, Asp5] Surfactin-C15 and hemoglobin in aqueous solution. Biomacromolecules 2010, 11, 593-599.
12. Stein, T. Bacillus subtilis antibiotics: Structures, syntheses and specific functions. Mol. Microbiol. 2005, 5, 845-857.
13. Makovitzki, A.; Baram, J.; Shai, Y. Antimicrobial lipopolypeptides composed of palmitoyl di- and tricationic peptides: In vitro and in vivo activities, self-assembly to nanostructures, and a plausible mode of action. Biochemistry 2008, 47, 10630-10636.
14. Shai, Y.; Makovitzky, A.; Avrahami, D. Host defense peptides and lipopeptides: Modes of action and potential candidates for the treatment of bacterial and fungal infections. Curr. Protein Pept. Sci. 2006, 7, 479-486.
15. Straus, S.K.; Hancock, R.E. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 2006, 1758, 1215-1223.
16. Thevissen, K.; Terras, F.R.; Broekaert, W.F. Permeabilization of fungal membranes by plant defensins inhibits fungal growth. Appl. Environ. Microbiol. 1999, 65, 5451-5458.
17. Hobden, C.; Teevan, C.; Jones, L.; O'Shea, P. Hydrophobic properties of the cell surface of Candida albicans: A role in aggregation. Microbiology 1995, 14, 1875-1881.
18. Kurtz, M.B.; Douglas, C.M. Lipopeptide inhibitors of fungal glucan synthase. J. Med. Vet. Mycol. 1997, 35, 79-86.
19. Thomas, D.N.; Dieckmann, G.S. Antarctic sea ice - A habitat for extremophiles. Science 2002, 295, 641-644.
20. Liu, X.; Ashforth, E.; Ren, B.; Song, F.; Dai, H.; Liu, M.; Wang, J.; Xie, Q.; Zhang, L. Bioprospecting microbial natural product libraries from the marine environment for drug discovery. J. Antibiot. 2010, 63, 415-422.
21. Marfey, P. Determination of D-amino acids. II. Use of a bifunctional reagent, 1-5-difluoro-2, 4-dinitrobenzene. Carlsberg Res. Commun. 1984, 49, 591-596.
22. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. High-field FT NMR application of Mosher's method. The absolute configuration of marine terpenoids. J. Am. Chem. Soc. 1991, 113, 4092-4096.
23. 1H NMR: Basis and applications. J. Org. Chem. 2005, 70, 3778-3790.
24. Jenske, R.; Vetter, W. Enantioselective analysis of 2- and 3-hydroxy fatty acids in food samples. J. Agric. Food Chem. 2008, 56, 11578-11583.
25. Maider, P.; Francoise, P.; Jean, W. Solid-phase synthesis of surfactin, a powerful biosurfactant produced by Bacillus subtilis, and of four analogues. Int. J. Pept. Res. Ther. 2005, 11, 195-202.
26. Appendio, G.; Gibbons, S.; Giana, A.; Pagani, A.; Grassi, G.; Stavri, M.; Smith, E.; Rahman, M.M. Antibacterial cannabinoids from Cannabis sativa: A structure-activity study. J. Nat. Prod. 2008, 71, 1427-1430.
27. Oluwatuyi, M.; Kaatz, G.W.; Gibbons, S. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 2004, 65, 3249-3254.
28. Yu, J.Q.; Lei, J.C.; Yu, H.D.; Cai, X.; Zou, G.L. Chemical composition and antimicrobial activity of the essential oil of Scutellaria barbata. Phytochemistry 2004, 65, 881-884.
29. Skehan, P.; Storeng, R; Scudiero, D.; Monks, A.; McMohan, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyed, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
30. Shaligram, N.S.; Singhal, R.S. Surfactin - A review on biosynthesis, fermentation, purification and applications. Food Technol. Biotechnol. 2010, 48, 119-134.
31. Batrakov, S.G.; Rodionova, T.A; Esipov, S.E.; Polyakov, N.B.; Sheichenko, V.I.; Shekhovtsova, N.V.; Lukin, S.M.; Panikov, N.S.; Nikolaev, Y.A. A novel lipopeptide, an inhibitor of bacterial adhesion, from the thermophilic and halotolerant subsurface Bacillus licheniformis strain 603. Biochim. Biophys. Acta 2003, 1634, 107-115.
32. Canova, S.P.; Petta, T.; Reyes, L.F.; Zucchi, T.D.; Moraes, L.A.B.; Melo, I.S. Characterization of lipopeptides from Paenibacillus sp. (IIRAC30) suppressing Rhizoctonia solani. World J. Microbiol. Biotechnol. 2010, 26, 2241-2247.
33. Kim, S.Y.; Kim, J.Y.; Kim, S.H.; Bae, H.J.; Yi, H.; Yoon, S.H.; Koo, B.S.; Kwon, M.; Cho, J.Y.; Lee C.H.; et al. Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett. 2007, 581, 865-871.
34. Wang, C.L.; Ng, T.B.; Yuan, F.; Liu, Z.K.; Liu, F. Induction of apoptosis in human leukemia K562 cells by cyclic lipopeptide from Bacillus subtilis natto T-2. Peptides 2007, 28, 1344-1350.
35. Romano, A.; Vitullo, D.; Di, P.A.; Lima, G.; Lanzotti, V. Antifungal lipopeptides from Bacillus amyloliquefaciens strain BO7. J. Nat. Prod. 2011, 74, 145-151.
36. Kim, H.S.; Yoon, B.D.; Lee, C.H.; Suh, H.H.; Oh, H.M.; Katsuragi, T.; Tani, Y. Production and properties of a lipopeptide biosurfactant from Bacillus subtilis C9. J. Ferment. Bioeng. 1997, 84, 41-46.
37. Kim, P.I.; Bai, H.; Bai, D.; Chae, H.; Chung, S.; Kim, Y.; Park, R.; Chi, Y.T. Purification and characterization of a lipopeptide produced by Bacillus thuringiensis CMB26. J. Appl. Microbiol. 2004, 97, 942-949.